BB Biotech AG (XSWX:BION) FCF Yield %: 14.93 (As of Jun. 26, 2026) — 101% Above Median


XSWX:BION BB Biotech AG XSWX:BION
33 GF Score
Price CHF47.80
! 3 Warning Signs
View Full Analysis

What is BB Biotech AG FCF Yield %?

BB Biotech AG XSWX:BION +2.14% 33 FCF Yield % is 14.93 as of Jun. 26, 2026, which is 101% above its 10-year median of 7.41. GuruFocus rates XSWX:BION with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 1,418 Biotechnology companies, BB Biotech AG ranks better than 98.31% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, BB Biotech AG's Trailing 12-Month Free Cash Flow is CHF393.7 Mil, and Market Cap is CHF2,636.1 Mil. Therefore, BB Biotech AG's FCF Yield % for today is 14.93%.

The historical rank and industry rank for BB Biotech AG's FCF Yield % or its related term are showing as below:

XSWX:BION' s FCF Yield % Range Over the Past 10 Years
Min: -11.07   Med: 7.41   Max: 36.85
Current: 14.93


During the past 13 years, the highest FCF Yield % of BB Biotech AG was 36.85%. The lowest was -11.07%. And the median was 7.41%.

XSWX:BION's FCF Yield % is ranked better than
98.31% of 1418 companies
in the Biotechnology industry
Industry Median: -9.64 vs XSWX:BION: 14.93

BB Biotech AG's FCF Margin % for the quarter that ended in Mar. 2026 was -2,193.24%.


BB Biotech AG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


BB Biotech AG FCF Yield % Related Terms


BB Biotech AG FCF Yield % Historical Data

* Premium members only.

The historical data trend for BB Biotech AG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BB Biotech AG FCF Yield % Chart

BB Biotech AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.22 7.63 9.31 15.71 12.47

BB Biotech AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.23 -14.54 12.77 2.60 60.98

XSWX:BION vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, BB Biotech AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's FCF Yield % falls into.


XSWX:BION
33GF Score
BB Biotech AG XSWX:BION
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

BB Biotech AG's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=309.145 / 2478.94755
=12.47%

BB Biotech AG's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=373.707 * 4 / 2451.37305
=60.98%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 14.93 mean?
BB Biotech AG (XSWX:BION) has a FCF Yield % of 14.93 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on BB Biotech AG and its competitors. This is 101% above median its historical median of 7.41. According to the industry distribution chart, BB Biotech AG ranks #24 out of 1418 companies in the Biotechnology industry, placing it in the top 1.7%.
Is BB Biotech AG's FCF Yield % too high?
BB Biotech AG's current FCF Yield % of 14.93 is 101% above median its 10-year median of 7.41. Based on the distribution chart, BB Biotech AG ranks #24 out of 1418 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, BB Biotech AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #24 out of 1418 companies for FCF Yield %. This places BB Biotech AG in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on BB Biotech AG and its competitors. BB Biotech AG's current FCF Yield % is 14.93, which is 101% above median its own 10-year median of 7.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current FCF Yield % of 14.93. The current FCF Yield % is 14.93, which is 101% above median its 10-year median of 7.41. BB Biotech AG's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current FCF Yield % is 14.93 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
33GF Score

Get the complete analysis for XSWX:BION

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF47.80
Price